Literature DB >> 30076742

Iron metabolism gene expression and prognostic features of hepatocellular carcinoma.

Ying Shen1,2, Xin Li1,2, Bin Zhao1,2, Yanru Xue1,2, Shenghang Wang1,2, Xin Chen1,2, Jiancheng Yang1,2, Huanhuan Lv1,2, Peng Shang2,3.   

Abstract

Iron metabolism is crucial to hepatocellular carcinoma progression and is a key determinant of prognosis. Protein-protein interactions within the iron metabolism gene network were analyzed using the European Molecular Biology Laboratory's Search Tool for Recurring Instances of Neighbouring Genes/Proteins database. We obtained 423 liver hepatocellular carcinoma gene expression profiles from the Cancer Genome Atlas database. The expression and pathway enrichment of representative iron intake genes (TFRC and DMT1), utilization genes (FTH1, FTL, HIF1A, HMOX1, SLC25A37, and SLC25A38), and efflux genes (FLVCR1 and SLC40A1) was investigated in tumor and adjacent tissues. We determined the relationship between iron metabolism and the prognostic features of liver hepatocellular carcinoma. The liver metabolism genes TFRC and FLVCR1 were related to survival, disease status, and prognosis in patients with hepatocellular carcinoma. Our results provide novel insight into liver cancer therapy.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  TCGA; bioinformatics; hepatocellular carcinoma (HCC); iron metabolism; prognosis

Mesh:

Substances:

Year:  2018        PMID: 30076742     DOI: 10.1002/jcb.27184

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  17 in total

1.  Ferroptosis-related genes for predicting prognosis of patients with laryngeal squamous cell carcinoma.

Authors:  Fang Han; Wenfei Li; Tao Chen; Yutong Yao; Jinglong Li; Di Wang; Zhanqiu Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-04-05       Impact factor: 2.503

2.  Sphingosine-1-phosphate transporter spinster homolog 2 is essential for iron-regulated metastasis of hepatocellular carcinoma.

Authors:  Min Li; Yuxiao Tang; Dongyao Wang; Xiaofeng Zhai; Hui Shen; Chen Zhong; Man Yao; Aiguo Jin; Zhengjun Zhou; Shaolai Zhou; Jia Fan; Chang-Quan Ling; Chen Ling
Journal:  Mol Ther       Date:  2021-09-20       Impact factor: 11.454

3.  Identification of Key Genes for Hepatitis Delta Virus-Related Hepatocellular Carcinoma by Bioinformatics Analysis.

Authors:  Cheng Zhang; Shan Wu; Xiao-Dong Yang; Hui Xu; Tai Ma; Qi-Xing Zhu
Journal:  Turk J Gastroenterol       Date:  2021-02       Impact factor: 1.852

4.  A Novel 8-Gene Prognostic Signature for Survival Prediction of Uveal Melanoma.

Authors:  Zhongjun Tang; Kebo Cai
Journal:  Anal Cell Pathol (Amst)       Date:  2021-08-14       Impact factor: 2.916

5.  Genome‑wide investigation of the clinical implications and molecular mechanism of long noncoding RNA LINC00668 and protein‑coding genes in hepatocellular carcinoma.

Authors:  Xiangkun Wang; Xin Zhou; Junqi Liu; Zhengqian Liu; Linbo Zhang; Yizhen Gong; Jianlu Huang; Long Yu; Qiaoqi Wang; Chengkun Yang; Xiwen Liao; Tingdong Yu; Chuangye Han; Guangzhi Zhu; Xinping Ye; Tao Peng
Journal:  Int J Oncol       Date:  2019-08-14       Impact factor: 5.650

6.  Identification of an autophagy-related gene signature predicting overall survival for hepatocellular carcinoma.

Authors:  Wenfang Xu; Wenke Guo; Ping Lu; Duan Ma; Lei Liu; Fudong Yu
Journal:  Biosci Rep       Date:  2021-01-29       Impact factor: 3.840

7.  FLVCR1 Predicts Poor Prognosis and Promotes Malignant Phenotype in Esophageal Squamous Cell Carcinoma via Upregulating CSE1L.

Authors:  Suna Zhou; Mingxin Zhang; Chao Zhou; Yinnan Meng; Haihua Yang; Wenguang Ye
Journal:  Front Oncol       Date:  2021-03-25       Impact factor: 6.244

Review 8.  Iron Dysregulation in Human Cancer: Altered Metabolism, Biomarkers for Diagnosis, Prognosis, Monitoring and Rationale for Therapy.

Authors:  Pierre Lelièvre; Lucie Sancey; Jean-Luc Coll; Aurélien Deniaud; Benoit Busser
Journal:  Cancers (Basel)       Date:  2020-11-26       Impact factor: 6.639

Review 9.  Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents.

Authors:  Pierre V Candelaria; Lai Sum Leoh; Manuel L Penichet; Tracy R Daniels-Wells
Journal:  Front Immunol       Date:  2021-03-17       Impact factor: 7.561

Review 10.  The Multifaceted Role of Heme in Cancer.

Authors:  Veronica Fiorito; Deborah Chiabrando; Sara Petrillo; Francesca Bertino; Emanuela Tolosano
Journal:  Front Oncol       Date:  2020-01-15       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.